mortality/aging
• between 9 and 24 months mice succumb to cancer; median survival is 16 months
|
neoplasm
• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice
|
• in one mouse
|
• in 13 of 15 mice with no evidence of metastasis
|
• one mouse developed a gastric adenoma
|
• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice
|
• 24% of mice develop nodal lymphomas compared with 6% of wild-type mice
|
• in 36% of mice compared with 22% of wild-type mice
|
• 12% of mice develop lung adenomas and adenocarcinomas compared with 9% of wild-type mice
|
immune system
• in mice some mice
|
hematopoietic system
• in mice some mice
|
digestive/alimentary system
• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice
|
• in one mouse
|
• in 13 of 15 mice with no evidence of metastasis
|
• 45% of mice develop intestinal adenomas and adenocarcinomas compared with 5% of wild-type mice
|
growth/size/body
• in mice some mice
|
respiratory system
• 12% of mice develop lung adenomas and adenocarcinomas compared with 9% of wild-type mice
|